Project Grant R01NS148365
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded UC San Diego a $572,114 Project Grant (CFDA 93.853: Extramural Research Programs in the Neurosciences and Neurological Disorders) effective August 15, 2025, with a completion date of June 30, 2030. This award funds research on progressive lengthening for peripheral nerve repair, a novel surgical approach designed to address large nerve gap injuries resulting from trauma or surgical...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Washington University a Project Grant totaling $567,037 beginning August 1, 2025, through July 31, 2030, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This award supports research to characterize the synchronous relationship between peripheral nerve post-injury activity and brain plasticity following traumatic peripheral nerve...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the Regents of the University of Michigan a Project Grant totaling $531,478 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective August 1, 2025, through July 31, 2030, supports fundamental research investigating the immune metabolic mechanisms underlying peripheral nervous system (PNS) degeneration and regeneration...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded University of California, Los Angeles $407,739 on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This two-year project grant, extending through July 31, 2027, supports basic neuroscience research investigating the regulation of axon caliber in sensory neurons, with particular focus on the role of...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Ohio State University a $540,322 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective August 1, 2025, through July 31, 2027. This award funds research investigating the role of three-dimensional (3D) chromatin architecture in axonal regeneration following peripheral nerve injury. The project addresses the...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded New Jersey Institute of Technology a Project Grant of $553,292 on March 11, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award funds the development of a three-dimensional (3D) in vitro tissue construct designed to study peripheral nerve regeneration and axonal growth. The research addresses peripheral nerve injury...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $236,250 to the University of California, Los Angeles (UCLA) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on May 15, 2026, with completion targeted for April 30, 2028. This R21 Project Grant supports research investigating the relationship between T cell senescence and chronic inflammatory demyelinating polyneuropathy...
- Federal Project Grant Award Summary The University of Utah received a $1,188,230 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective July 15, 2025, through June 30, 2030. This research initiative investigates the pathophysiology of neuroma formation following closed-mechanism peripheral nerve injuries. The project will characterize...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Wisconsin-Madison a Project Grant totaling $936,624 on June 27, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research project, titled "Regulation of Invadosome-Mediated Peripheral Axon Guidance by ErbB Signaling," will be conducted through March 31, 2030, and addresses fundamental...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $343,610 to the University of California, San Diego on June 26, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) for a project on learning-induced synaptic plasticity in corticospinal output neurons of motor cortex. The research will be completed by November 30, 2026, and focuses on advancing understanding of how the...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded University of California, Los Angeles a Project Grant totaling $495,164 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, effective June 1, 2026, through May 31, 2031, supports research investigating the mechanisms of Schwann cell development and plasticity in peripheral nerve regeneration. The research focuses on characterizing how the MITF (Microphthalmia-associated Transcription Factor) transcription factor integrates injury-derived signaling to drive Schwann cell reprogramming into repair cells, which is essential for axonal regeneration and functional recovery following peripheral nerve injury. Using integrated molecular, genetic, imaging, transcriptomic, and proteomic approaches, the investigators will elucidate how extracellular injury signals are transmitted through cytoplasmic cascades to modulate nuclear transcriptional programs that enable effective repair cell formation. This research addresses a significant clinical gap in understanding peripheral nervous system disorders that impair motor function and alter pain sensitivity. By identifying the molecular mechanisms controlling Schwann cell plasticity, the project aims to advance therapeutic development strategies for peripheral nerve regeneration, ultimately contributing to more effective treatment approaches for currently incurable peripheral nerve injuries and diseases.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $495.2k | 5/18/26 |